GB202013912D0 - Single-dose live-attenuated YF17D-vectored vaccine against SARS-CoV-2 - Google Patents

Single-dose live-attenuated YF17D-vectored vaccine against SARS-CoV-2

Info

Publication number
GB202013912D0
GB202013912D0 GBGB2013912.7A GB202013912A GB202013912D0 GB 202013912 D0 GB202013912 D0 GB 202013912D0 GB 202013912 A GB202013912 A GB 202013912A GB 202013912 D0 GB202013912 D0 GB 202013912D0
Authority
GB
United Kingdom
Prior art keywords
yf17d
cov
attenuated
vaccine against
against sars
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2013912.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Katholieke Universiteit Leuven
Original Assignee
Katholieke Universiteit Leuven
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Katholieke Universiteit Leuven filed Critical Katholieke Universiteit Leuven
Priority to GBGB2013912.7A priority Critical patent/GB202013912D0/en
Publication of GB202013912D0 publication Critical patent/GB202013912D0/en
Priority to CA3168673A priority patent/CA3168673A1/en
Priority to AU2021225362A priority patent/AU2021225362A1/en
Priority to EP21706473.2A priority patent/EP4110380A1/en
Priority to JP2022550759A priority patent/JP2023516149A/en
Priority to US17/802,001 priority patent/US20230241201A1/en
Priority to PCT/EP2021/055013 priority patent/WO2021170869A1/en
Ceased legal-status Critical Current

Links

GBGB2013912.7A 2020-02-27 2020-09-04 Single-dose live-attenuated YF17D-vectored vaccine against SARS-CoV-2 Ceased GB202013912D0 (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GBGB2013912.7A GB202013912D0 (en) 2020-09-04 2020-09-04 Single-dose live-attenuated YF17D-vectored vaccine against SARS-CoV-2
CA3168673A CA3168673A1 (en) 2020-02-27 2021-03-01 Coronavirus vaccines
AU2021225362A AU2021225362A1 (en) 2020-02-27 2021-03-01 Coronavirus vaccines
EP21706473.2A EP4110380A1 (en) 2020-02-27 2021-03-01 Coronavirus vaccines
JP2022550759A JP2023516149A (en) 2020-02-27 2021-03-01 coronavirus vaccine
US17/802,001 US20230241201A1 (en) 2020-02-27 2021-03-01 Coronavirus vaccines
PCT/EP2021/055013 WO2021170869A1 (en) 2020-02-27 2021-03-01 Coronavirus vaccines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2013912.7A GB202013912D0 (en) 2020-09-04 2020-09-04 Single-dose live-attenuated YF17D-vectored vaccine against SARS-CoV-2

Publications (1)

Publication Number Publication Date
GB202013912D0 true GB202013912D0 (en) 2020-10-21

Family

ID=72841335

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2013912.7A Ceased GB202013912D0 (en) 2020-02-27 2020-09-04 Single-dose live-attenuated YF17D-vectored vaccine against SARS-CoV-2

Country Status (1)

Country Link
GB (1) GB202013912D0 (en)

Similar Documents

Publication Publication Date Title
GB202010425D0 (en) Combination vaccine
GB2592769B (en) CpG-Adjuvanted SARS-CoV-2 virus vaccine
HK1250136A1 (en) Vaccine compositions having improved stability and immunogenicity
GB202002166D0 (en) Vaccine
GB201910794D0 (en) Vaccine
GB202016954D0 (en) Vaccine
GB202013912D0 (en) Single-dose live-attenuated YF17D-vectored vaccine against SARS-CoV-2
GB202010479D0 (en) Single-dose live-attenuated YF17D-vectored vaccine against SARS-CoV-2
GB202004825D0 (en) Influenza vaccines
GB202119115D0 (en) Vaccine
GB202118110D0 (en) Vaccine
GB202114274D0 (en) SARS-CoV-2 vaccine
GB202112149D0 (en) Shigellla vaccine
GB202102677D0 (en) Vaccine
GB202016165D0 (en) Vaccine
GB202014719D0 (en) Vaccine
GB202013541D0 (en) Vaccine
GB202013534D0 (en) Vaccine
GB202013253D0 (en) Vaccine
GB202009402D0 (en) Vaccine
GB202005878D0 (en) Vaccine
GB202005880D0 (en) Vaccine
GB202003292D0 (en) Vaccine
GB202003289D0 (en) Vaccine
GB202116831D0 (en) Vaccines

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)